News

Scientists will work in the Boehringer Ingelheim-Tsinghua University Joint Research Center for Immuno-Infection to harness the mechanisms of immune modulation to combat infectious diseases. The collaboration brings together

Redx will now work with the investigators to finalize this protocol, with the intention of restarting dosing of patients in the first half of 2019. Based on a

Merkel cell carcinoma is a rare form of skin cancer caused by a Merkel cell associated polyomavirus. The company’s supplemental biologics license application (sBLA), which has been accepted

Over this period, CHDI may fund up to 75 full-time scientists at Evotec. The collaboration was initiated in 2006 and has grown considerably over this period to fully

Olon CEO Paolo Tubertini said: “By acquiring a manufacturing base in India, Olon will have the opportunity to accelerate growth by adding new CDMO projects and to develop

Cablivi is claimed to be the first therapeutic specifically developed to treat aTTP, a rare blood-clotting disorder. The approval was based on data from the phase II Titan

The planned 90,000ft² quality control facility, which will have 12 production suites, is expected to enable Wasdell to provide quality control (QC) import testing for pharmaceutical products. To

The initial recommended prophylactic regimen for Jivi is twice weekly with the ability to dose every five days and further individually adjust to less or more frequent dosing

The franchise includes the global rights to ONCASPAR and ex-US and ex-Taiwan rights to ONIVYDE, as well as Oncology pipeline assets.  David Lee, who was previously the head